Aim: To identify the demographics and trends of individuals intending to donate their organs, based on intentions at the time of driver's license registration.
Methods: Data were collected from 4 742 475 individuals first registering for a New Zealand (NZ) driver's license, between January 1, 1974, and November 16, 2023, with positive or negative organ donor intentions recorded. Gender, ethnicity, and year of registration were collected. Predictors of positive organ donation intention were examined with a multivariate logistic regression model.
Results: A positive response to the question regarding organ donation intentions was reported in 2 476 914 individuals (52.2%). This included 1 201 275 males (48.4%) and 1 275 639 females (56.4%). Positive organ donation intention was reported in 1 695 672 NZ Europeans (66.2%), 246 303 Māori (36.2%), 76 749 Pasifika (27.6%), 273 879 Asians (34.4%), 52 137 Middle Eastern, Latin American and African (MELAA) (47.0%), 48 876 "Other" ethnicity (63.5%), and 83 298 "Not otherwise specified" (34.7%). On multivariate logistic regression, the female gender was associated with an increased likelihood of organ donation intention (OR 1.37, p < 0.001), and driver's license registration in a more recent year was associated with an increased likelihood of organ donation intention (OR 1.02, p < 0.001). Compared to all other ethnicities, NZ Europeans were associated with a higher likelihood of positive organ donation intention.
Conclusions: This is the largest study of organ donation intention published in Australasia. It demonstrates a higher likelihood of organ donation intentions in females, ethnic differences, and increasing donation intention rates over time. Further investigation is required to explore the difference between intentions and end-of-life organ donation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/ctr.70089 | DOI Listing |
Zool Res
January 2025
Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong 510280, China. E-mail:
Severe combined immunodeficiency disease (SCID), characterized by profound immune system dysfunction, can lead to life-threatening infections and death. Animal models play a pivotal role in elucidating biological processes and advancing therapeutic strategies. Recent advances in gene-editing technologies, including zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), CRISPR/Cas9, and base editing, have significantly enhanced the generation of SCID models.
View Article and Find Full Text PDFFront Transplant
January 2025
Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN, United States.
Introduction: The clinical characteristics of inflammatory bowel disease (dnIBD) diagnosed after solid organ transplant (SOT) are not well-described, particularly since the advent of biologic therapy for treatment of IBD.
Methods: We conducted a single-center, retrospective review of SOT recipients between 2010 and 2022 at the University of Minnesota Medical Center who were diagnosed with IBD after transplant.
Results: Of 89 patients at our center with IBD and a history of SOT, five (5.
Front Immunol
January 2025
Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.
Introduction: Mycophenolate mofetil (MMF) is an immunosuppressive drug administered in the management of both autoimmune diseases and organ transplantation. The main aims of the study were: (a) to obtain information regarding the safety of using MMF in respect of its effect on normal T and B cells in lymphoid tissues; (b) to investigate whether the generation of inducible Foxp3-expressing regulatory T cells (Treg) might constitute additional mechanisms underlying the immunosuppressive properties of MMF.
Methods: The effect of MMF ( studies) and its active metabolite, mycophenolic acid, ( studies) on murine CD4 and CD8 T cells as well as B cells was determined, regarding: (a) absolute count, proliferation and apoptosis of these cells ( studies); (b) absolute count of these cells in the head and neck lymph nodes, mesenteric lymph nodes and the spleen ( studies).
Front Public Health
January 2025
Transplant Immunology Unit, Geneva University Hospitals, Geneva, Switzerland.
Introduction: The Swiss allocation system for kidney transplantation has evolved over time to balance medical urgency, immunological compatibility, and waiting time. Since the introduction of the transplantation law in 2007, which imposed organ allocation on a national level, the algorithm has been optimized. Initially based on waiting time, HLA compatibility, and crossmatch performed by cell complement-dependent cytotoxicity techniques, the system moved in 2012 to a score including HLA compatibility, waiting time, anti-HLA antibodies detected by the Luminex technology, and a virtual crossmatch.
View Article and Find Full Text PDFSurg Pract Sci
June 2024
Department of Surgery, Westchester Medical Center and New York Medical College, Valhalla, NY, USA.
Background: While hepatocellular carcinoma (HCC) remains the leading cause of liver transplant (LT) for liver tumors, indications have broadened over the years. Data regarding patient characteristics and outcomes of LT for liver tumors are limited.
Methods: From Jan-2002 to March-2022, 14,406 LT recipients for various liver tumors were identified in United Network for Organ Sharing database.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!